Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial dysbiosis refers to a disruption or imbalance of the normal microbial communities (microbiota) that inhabit body sites such as the gut, skin, or mucosa. In healthy individuals, these communities perform essential roles in digestion, immune regulation, and protection against pathogens. When this balance is disturbed—due to factors like antibiotics, poor diet, stress, infection, or environmental exposures—the resulting dysbiosis is associated with a wide range of diseases, including inflammatory, metabolic, neurodegenerative, and malignant conditions. Therapeutic strategies aim to restore a healthy microbiome through dietary changes, targeted antibiotics, probiotics, prebiotics, or fecal microbiota transplantation. However, as a community-level state rather than a discrete molecular entity, "microbial dysbiosis" is not a canonical molecular target or receptor, but rather a disease process or condition to be managed or corrected. In summary: "Microbial dysbiosis" describes an abnormal community state, not a molecular target or receptor. It is critical in health and disease, but not a druggable entity itself; instead, interventions act to shift the overall community composition or function.
Restoration of normal microbial community structure (e.g., FMT rebalances microbiota); Removal of pathogenic or overgrown species (e.g., antibiotics); Support of beneficial microbes (e.g., probiotics/prebiotics).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial dysbiosis.